Neil Averitt commentary: CVS-Aetna deal has many good features, but what of the PBMs?
Much good can be said about the planned merger of CVS and Aetna, but there is also a potentially troublesome sleeper issue involving pharmacy benefit management services, which should be looked...
Subscription required to view this article.
This content can only be accessed by FTCWatch subscribers. If you are an FTCWatch subscriber, please login to access this contentIf you do not currently subscribe to FTCWatch please contact us for subscription information:
Email: customerservices@mlex.com
FTCWatch is delivered in the following formats: via email alert and online at mlexwatch.com/ftcwatch
